Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

MECHANISM OF BLOCK AND BEHAVIORAL EFFECTS OF THE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS MEMANTINE AND KETAMINE

Kotermanski, Shawn Edward (2009) MECHANISM OF BLOCK AND BEHAVIORAL EFFECTS OF THE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS MEMANTINE AND KETAMINE. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

[img]
Preview
PDF
Primary Text

Download (1MB) | Preview

Abstract

Pharmacological inhibition of NMDA receptor activity by ketamine is accompanied by pyschotomimetic side-effects; however, the Alzheimer's disease therapeutic memantine blocks NMDA receptor activity without debilitating side-effects. This dissertation provides electrophysiological and behavioral characterizations of these two NMDA receptor antagonists in an attempt to understand the unique therapeutic utility of memantine. The following work explores memantine and ketamine inhibition at NMDA receptors, their main site of action, with a focus on the mechanism of inhibition and receptor subtype selectivity in physiologically relevant conditions. This research shows NMDA receptors possess a second binding site at which memantine, but not ketamine, can inhibit activity. The research also shows the dramatic effect physiological concentrations of magnesium has on the ability of these drugs to inhibit NMDA receptor activity. Behavioral and cognitive effects of memantine and ketamine are also assessed and compared directly in rat. The effects of memantine and ketamine in rat were found to be similar at the low doses tested and more divergent as dose increased. Furthermore, memantine's effects appeared to be more pronounced and longer-lasting than those of ketamine. These findings demonstrate the importance of considering the physiological environment in which a drug acts, as well as the principles of drug action, when examining the effects of a drug on central nervous system activity.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Kotermanski, Shawn Edwardsekst28@pitt.eduSEKST28
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairJohnson, Jon W
Committee MemberMoghaddam, Bita
Committee MemberWood, David C
Committee MemberThiels, Edda
Committee MemberVicini, Stefano
Committee MemberMeriney, Stephen D
Date: 28 January 2009
Date Type: Completion
Defense Date: 24 November 2008
Approval Date: 28 January 2009
Submission Date: 11 December 2008
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Institution: University of Pittsburgh
Schools and Programs: Dietrich School of Arts and Sciences > Neuroscience
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: Alzheimer's Disease; Ketamine; Memantine; NMDA; Patch-Clamp; Schizophrenia
Other ID: http://etd.library.pitt.edu/ETD/available/etd-12112008-131953/, etd-12112008-131953
Date Deposited: 10 Nov 2011 20:10
Last Modified: 15 Nov 2016 13:54
URI: http://d-scholarship.pitt.edu/id/eprint/10320

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item